AstraZeneca's proposed $39 billion deal for Alexion gets U.S. antitrust OK

Delaware Business Now

Apr 21, 2021

Reading Time: < 1 minute AstraZeneca's proposed acquisition of Alexion Pharmaceuticals, Inc received an OK from federal antitrust regulators. It follows the conclusion of the waiti…